litlas
ログインアカウント作成

Michael T. Osterholm

1981–2025 年に発表

76
論文数
19,938
被引用数
55
h 指数
73
i10 指数

被引用数

Michael T. Osterholm の年別被引用数1952 年: 被引用 1 件1982 年: 被引用 2 件1983 年: 被引用 4 件1984 年: 被引用 3 件1985 年: 被引用 2 件1986 年: 被引用 6 件1987 年: 被引用 13 件1988 年: 被引用 17 件1989 年: 被引用 8 件1990 年: 被引用 15 件1991 年: 被引用 12 件1992 年: 被引用 13 件1993 年: 被引用 17 件1994 年: 被引用 23 件1995 年: 被引用 17 件1996 年: 被引用 47 件1997 年: 被引用 28 件1998 年: 被引用 40 件1999 年: 被引用 52 件2000 年: 被引用 63 件2001 年: 被引用 99 件2002 年: 被引用 177 件2003 年: 被引用 199 件2004 年: 被引用 160 件2005 年: 被引用 192 件2006 年: 被引用 209 件2007 年: 被引用 133 件2008 年: 被引用 133 件2009 年: 被引用 125 件2010 年: 被引用 104 件2011 年: 被引用 91 件2012 年: 被引用 107 件2013 年: 被引用 120 件2014 年: 被引用 106 件2015 年: 被引用 92 件2016 年: 被引用 78 件2017 年: 被引用 97 件2018 年: 被引用 76 件2019 年: 被引用 298 件2020 年: 被引用 290 件2021 年: 被引用 260 件2022 年: 被引用 212 件2023 年: 被引用 110 件2024 年: 被引用 185 件2025 年: 被引用 87 件2026 年: 被引用 6 件1953〜1981 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,094 件、この内訳の 39.3%イギリス: 引用元論文 390 件、この内訳の 7.3%カナダ: 引用元論文 261 件、この内訳の 4.9%中国: 引用元論文 175 件、この内訳の 3.3%フランス: 引用元論文 157 件、この内訳の 3%ドイツ: 引用元論文 150 件、この内訳の 2.8%オーストラリア: 引用元論文 148 件、この内訳の 2.8%イタリア: 引用元論文 146 件、この内訳の 2.7%スイス: 引用元論文 112 件、この内訳の 2.1%スウェーデン: 引用元論文 104 件、この内訳の 2%インド: 引用元論文 98 件、この内訳の 1.8%オランダ: 引用元論文 93 件、この内訳の 1.7%
0%39.3%その他 26.3%

機関

分野

  • Medicine49.7%
  • Biochemistry, Genetics and Molecular Biology21.8%
  • Immunology and Microbiology10.8%
  • Agricultural and Biological Sciences7.7%
  • Environmental Science2.2%
  • Social Sciences1.7%
  • その他6.1%

トピック

  • Influenza Virus Research Studies6.8%
  • Bacillus and Francisella bacterial research4.8%
  • Respiratory viral infections research4.6%
  • Viral gastroenteritis research and epidemiology3.8%
  • Salmonella and Campylobacter epidemiology3.1%
  • Viral Infections and Outbreaks Research3%
  • その他73.9%

共著者

全論文

検索で開く
  1. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

    著者: Michael T. Osterholm, Nicholas S. Kelley, Alfred Sommer, Edward A. Belongia - The Lancet Infectious Diseases 2011 被引用: 1,801

  2. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

    著者: Edward A. Belongia, Melissa Simpson, Jennifer P. King, Maria E. Sundaram, Nicholas S. Kelley, Michael T. Osterholm, Huong Q. McLean - The Lancet Infectious Diseases 2016 被引用: 701

  3. Tularemia as a Biological Weapon

    著者: David T. Dennis, Thomas V. Inglesby, Donald A. Henderson, John G. Bartlett, Michael S. Ascher, Edward M. Eitzen, Anne D. Fine, Arthur M. Friedlander, Jerome Hauer, Marcelle Layton, Scott R. Lillibridge, Joseph E. McDade, Michael T. Osterholm, Tara O’Toole, Gerald Parker, Trish M. Perl, Philip K. Russell, Kevin Tonat, for the Working Group on Civilian Biodefense - JAMA 2001 被引用: 1,402

  4. Botulinum Toxin as a Biological Weapon

    著者: S. S. Arnon, Robert Schechter, Thomas V. Inglesby, Donald A. Henderson, John G. Bartlett, Michael S. Ascher, Edward M. Eitzen, Anne D. Fine, Jerome Hauer, Marcelle Layton, Scott R. Lillibridge, Michael T. Osterholm, Tara O’Toole, Gerald Parker, Trish M. Perl, Philip K. Russell, David L. Swerdlow, Kevin Tonat, for the Working Group on Civilian Biodefense - JAMA 2001 被引用: 1,805

  5. A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future

    著者: Kristine A. Moore, Julie Ostrowsky, Alison M. Kraigsley, Angela J Mehr, Joseph Bresee, Martin Friede, Bruce G. Gellin, Josephine P Golding, Peter Hart, Ann Moen, Charlotte Weller, Michael T. Osterholm, William Ampofo, William Barclay, Marco Cavaleri, Cheryl Cohen, Benjamin J. Cowling, Rebecca Jane Cox, Ian D. Gust, Bruce L. Innis, Gagandeep Kang, Jacqueline M. Katz, Florian Krammer, Punnee Pitisuttithum, Diane J. Post, Larisa Rudenko, Marilda Mendonça Siqueira, Jerry P. Weir - Vaccine 2021 被引用: 70

  6. Measures to prevent and treat Nipah virus disease: research priorities for 2024–29

    著者: Kristine A Moore, Angela J Mehr, Julie Ostrowsky, Angela K. Ulrich, Nicolina M Moua, Petra C Fay, Peter Hart, Josephine P Golding, Virginia Benassi, Marie-Pierre Preziosi, Christopher C. Broder, Emmie de Wit, Pierre Formenty, Alexander N. Freiberg, Emily S. Gurley, Kim Halpin, Stephen P. Luby, Laura T Mazzola, Joel M. Montgomery, Christina F. Spiropoulou, Devendra T. Mourya, Shahana Parveen, Mahmudur Rahman, Cathy Roth, Lin‐Fa Wang, Michael T. Osterholm - The Lancet Infectious Diseases 2024 被引用: 54

  7. Practice Guidelines for the Management of Infectious Diarrhea

    著者: Richard L. Guerrant, Thomas Van Gilder, Ted S. Steiner, Nathan M. Thielman, Laurence Slutsker, Robert V. Tauxe, Thomas Hennessy, Patricia M. Griffin, Herbert L. DuPont, R. Bradley Sack, Phillip I. Tarr, Marguerite A. Neill, Irving Nachamkin, L. Barth Reller, Michael T. Osterholm, Michael L. Bennish, Larry K. Pickering - Clinical Infectious Diseases 2001 被引用: 1,076

  8. A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy

    著者: Kristine A. Moore, T. Leighton, Julie Ostrowsky, Cory Anderson, Richard Danila, Angela K. Ulrich, Eve Lackritz, Angela J Mehr, Ralph S. Baric, Norman W. Baylor, Bruce G. Gellin, Jennifer L. Gordon, Florian Krammer, Stanley Perlman, Helen Rees, Mélanie Saville, Charlotte Weller, Michael T. Osterholm - Vaccine 2023 被引用: 25

  9. Social, cultural and economic aspects of antimicrobial resistance

    著者: Timo Minssen, Kevin Outterson, Susan Rogers Van Katwyk, Pedro Henrique Dias Batista, Clare Chandler, Francesco Ciabuschi, Stéphan Harbarth, Aaron S. Kesselheim, Ramanan Laxminarayan, Kathleen Liddell, Michael T. Osterholm, Lance B. Price, Steven J. Hoffman - Bulletin of the World Health Organization 2020 被引用: 30

  10. Smallpox as a Biological Weapon

    著者: Donald A. Henderson, Thomas V. Inglesby, John G. Bartlett, Michael S. Ascher, Edward M. Eitzen, Peter B. Jahrling, Jerome Hauer, Marcelle Layton, Joseph E. McDade, Michael T. Osterholm, Tara O'Toole, Gerald Parker, Trish M. Perl, Philip K. Russell, Kevin Tonat, for the Working Group on Civilian Biodefense - JAMA 1999 被引用: 1,546

  11. Anthrax as a Biological Weapon, 2002

    著者: Thomas V. Inglesby, Tara O’Toole, Donald A. Henderson, John G. Bartlett, Michael S. Ascher, Edward M. Eitzen, Arthur M. Friedlander, Julie L. Gerberding, Jerome Hauer, James M. Hughes, Joseph E. McDade, Michael T. Osterholm, Gerald Parker, Trish M. Perl, Philip K. Russell, Kevin Tonat, for the Working Group on Civilian Biodefense - JAMA 2002 被引用: 1,018

  12. Development and deployment of COVID-19 vaccines for those most vulnerable

    著者: Wayne C. Koff, Theodore Schenkelberg, Tere Williams, Ralph S. Baric, Adrian B. McDermott, Cheryl Cameron, Mark J. Cameron, Matthew B. Frieman, Gabriele Neumann, Yoshihiro Kawaoka, Alyson A. Kelvin, Ted M. Ross, Stacey Schultz‐Cherry, Timothy D. Mastro, Frances Priddy, Kristine A. Moore, Julie Ostrowsky, Michael T. Osterholm, Jaap Goudsmit - Science Translational Medicine 2021 被引用: 88

  13. Hemorrhagic Fever Viruses as Biological Weapons

    著者: Luciana Borio, Thomas V. Inglesby, C. J. Peters, Alan Schmaljohn, James M. Hughes, Peter B. Jahrling, Thomas G. Ksiazek, Karl M. Johnson, Andrea Meyerhoff, Tara O’Toole, Michael S. Ascher, John Bartlett, Joel G. Breman, Edward M. Eitzen, Margaret Hamburg, Jerry Hauer, D. A. Henderson, Richard T. Johnson, Gigi Kwik, Marci Layton, Scott R. Lillibridge, Gary J. Nabel, Michael T. Osterholm, Trish M. Perl, Philip K. Russell, Kevin Tonat, for the Working Group on Civilian Biodefense - JAMA 2002 被引用: 675

  14. Infectious Disease Threats: A Rebound To Resilience

    著者: Peter Daszak, Gerald T. Keusch, Alexandra Phelan, Christine K. Johnson, Michael T. Osterholm - Health Affairs 2021 被引用: 80

  15. Tracking progress in universal influenza vaccine development

    著者: Julie Ostrowsky, Meredith Arpey, Kristine A. Moore, Michael T. Osterholm, Martin Friede, Jennifer L. Gordon, Deborah Higgins, Julia Molto-Lopez, Jonathan R. Seals, Joseph Bresee - Current Opinion in Virology 2020 被引用: 30

  16. Lassa fever research priorities: towards effective medical countermeasures by the end of the decade

    著者: Kristine A. Moore, Julia T Ostrowsky, Angela J Mehr, Rebecca A Johnson, Angela K. Ulrich, Nicolina M Moua, Petra C Fay, Peter Hart, Josephine P Golding, Virginia Benassi, Marie-Pierre Preziosi, Ifedayo M Adetifa, George O. Akpede, William Ampofo, Danny A Asogun, Alan D T Barrett, Daniel G. Bausch, Ilse De Coster, Devy Emperador, Heinz Feldmann, Élisabeth Fichet-Calvet, Pierre Formenty, Robert F. Garry, Donald S. Grant, Stephan Günther, Swati B. Gupta, Marie Jaspard, Laura T Mazzola, Sylvanus Okogbenin, Cathy Roth, Connie S. Schmaljohn, Michael T. Osterholm - The Lancet Infectious Diseases 2024 被引用: 29

  17. Quinolone-ResistantCampylobacter jejuniInfections in Minnesota, 1992–1998

    著者: Kirk Smith, John M. Besser, Craig W. Hedberg, Fe Leano, Jeff B. Bender, Julie H. Wicklund, Brian P. Johnson, Kristine A. Moore, Michael T. Osterholm - New England Journal of Medicine 1999 被引用: 668

  18. A National Outbreak ofSalmonella enteritidisInfections from Ice Cream

    著者: Thomas W. Hennessy, Craig W. Hedberg, Laurence Slutsker, Karen E. White, John M. Besser-Wiek, Michael E. Moen, John Feldman, William Coleman, Larry Edmonson, Kristine L. MacDonald, Michael T. Osterholm - New England Journal of Medicine 1996 被引用: 391

  19. Transmission of Ebola Viruses: What We Know and What We Do Not Know

    著者: Michael T. Osterholm, Kristine A. Moore, Nicholas S. Kelley, Lisa M. Brosseau, Gary Wong, Frederick A. Murphy, C. J. Peters, James W. LeDuc, Phillip K. Russell, Michel Van Herp, Jimmy Kapetshi, Jean-Jacques Tamfum Muyembe, Benoît Kebela Ilunga, James E. Strong, Allen Grolla, Anja Wolz, Brima Kargbo, David K. Kargbo, Pierre Formenty, David Avram Sanders, Gary Wong - mBio 2015 被引用: 223

  20. Chronic Wasting Disease in Cervids: Implications for Prion Transmission to Humans and Other Animal Species

    著者: Michael T. Osterholm, Cory Anderson, Mark D. Zabel, Joni Scheftel, Kristine A. Moore, Brian S. Appleby - mBio 2019 被引用: 87

  21. Critical Considerations for COVID-19 Vaccination of Refugees, Immigrants, and Migrants

    著者: Christine Thomas, Michael T. Osterholm, William M. Stauffer - American Journal of Tropical Medicine and Hygiene 2021 被引用: 76

  22. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Dose, Infection, and Disease Outcomes for Coronavirus Disease 2019 (COVID-19): A Review

    著者: Lisa M. Brosseau, Kevin Escandón-Vargas, Angela K. Ulrich, Angela L. Rasmussen, Chad J. Roy, Gregory Bix, Saskia Popescu, Kristine A. Moore, Michael T. Osterholm - Clinical Infectious Diseases 2021 被引用: 23

  23. Zika virus vaccines and monoclonal antibodies: a priority agenda for research and development

    著者: Julie Ostrowsky, Leah C. Katzelnick, Nigel Bourne, Alan D.T. Barrett, Stephen J. Thomas, Michael S Diamond, David W.C. Beasley, Eva Harris, Annelies Wilder‐Smith, T. Leighton, Angela J Mehr, Nicolina M Moua, Angela K. Ulrich, Ana Cehovin, Petra C Fay, Josephine P Golding, Kristine A. Moore, Michael T. Osterholm, Eve Lackritz, Eve M Lackritz, Kristina M Adams Waldorf, Alan D T Barrett, David W C Beasley, Joseph Y B Bennie, Nigel Bourne, Aaron C Brault, Ana Cehovin, Christiane Coelho, Michael S Diamond, Devy Emperador, Nuno R Faria, Petra C Fay, Josephine P Golding, Eva Harris, Nagwa Hasanin, Thomas Jaenisch, Albert I Ko, Eve M Lackritz, Eve M Lackritz, Tabitha Leighton, Yee-Sin Leo, Angela J Mehr, Ziad A Memish, Jairo A Méndez-Rico, Kristine A Moore, Manuela Mura, Lee-Ching Ng, Michael T Osterholm, Julia T Ostrowsky, Rosanna W Peeling, Ingrid B Rabe, Henrik Salje, J Erin Staples, Stephen J Thomas, Angela K Ulrich, Jessica Vanhomwegen, Jurai Wongsawat - The Lancet Infectious Diseases 2025 被引用: 19

  24. Design thinking during a health emergency: building a national data collection and reporting system

    著者: Kara Durski, Shalini Singaravelu, Dhamari Naidoo, Mamoudou Harouna Djingarey, Ibrahima Socé Fall, Ali Ahmed Yahaya, Bruce Aylward, Michael T. Osterholm, Pierre Formenty - BMC Public Health 2020 被引用: 14